TruTumor Systems
​
Advanced biological systems to preserve native contextures in the human tumor microenvironment
Capturing the heterogeneity in tumor response and resistance
Simultaneously comparing multiple therapies for a single tumor
Generating high quality "big data" with orthogonal assays
panCK CD8 CD3 CD68 Nucleus
Farcast proprietary image
Farcast Human Tumor Microdynamics Platform
Farcast Biosciences develops pioneering anthropic (true-to-human) biological systems, data, and Artificial Intelligence (AI) to decipher the true complexities of human tumor dynamics. And make cancer treatment more predictive and precise.
TruNet
Trusted relationships with network of global cancer centers for processing of multi-population tumor samples
PRECISION BIOSIGNATURES PREDICT CLINICAL RESPONSE
The Farcast technology platform generates high quality, multimodal data from its advanced anthropic (true-to-human) systems to truly capture the complexity of tumor response and resistance to treatments. Treatment response and resistance “big data” are mined using the platform's AI capabilities to discover biosignatures with higher predictive power compared to simplistic biomarkers. Over 24,000 human tumors have been processed by the platform in multiple solid tumor types, across multiple mechanisms and diverse population cohorts.
